Suppr超能文献

新型益生菌制剂胃肠道递释的微胶囊化:体外研究评估其活力和生物学特性。

Microencapsulation of new probiotic formulations for gastrointestinal delivery: in vitro study to assess viability and biological properties.

机构信息

Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.

Farcoderm Srl, San Martino Siccomario, Pavia, Italy.

出版信息

Appl Microbiol Biotechnol. 2015 Nov;99(22):9779-89. doi: 10.1007/s00253-015-6853-1. Epub 2015 Aug 4.

Abstract

The paper describes the preparation of new probiotic formulations based on chitosan-coated alginate microcapsules containing three different probiotic strains, Lactobacillus plantarum PBS067, Lactobacillus rhamnosus PBS070, and Bifidobacterium animalis subsp. lactis PBS075 taken individually and as a mixture of them. The effects of microencapsulation on the viability of the strains in conditions simulating the gastrointestinal tract and under industrial processes conditions were studied. In addition, an evaluation of their probiotic properties was also investigated by in vitro tests on the human intestinal cell line HT-29 to explore the effect of microencapsulation on health beneficial effect of the considered strains. Non-encapsulated cells were completely destroyed when exposed to simulated gastric juice and other stress conditions, while encapsulated cells exhibited a significantly higher resistance to artificial intestinal juice and heat and osmotic treatment. Moreover, in this study, the effect of the various microencapsulated probiotic strain formulations was compared with analogous formulations also containing the β-glucan Pleuran. The microencapsulation effectively protected the selected bacteria, as single strain and as a mixture of the three strains in both the formulations with and without Pleuran, from simulating gastrointestinal tract and industrial process conditions in delivering the viable cells without any significant adverse effect on their functionalities. The comparative study of the immunomodulatory properties of each single strain and the mixture of the three strains revealed a synergistic effect of the probiotic mixture, but no appreciable difference between the two kinds of formulations could be detected, as the effect of Pleuran is covered by the higher potential of the probiotic strains.

摘要

本文描述了基于壳聚糖包被的海藻酸钠微胶囊的新型益生菌制剂的制备,其中包含三种不同的益生菌菌株,即植物乳杆菌 PBS067、鼠李糖乳杆菌 PBS070 和动物双歧杆菌亚种。乳杆菌 PBS075,分别单独使用和混合使用。研究了微囊化对模拟胃肠道条件和工业过程条件下菌株活力的影响。此外,还通过体外测试人肠细胞系 HT-29 对其益生菌特性进行了评估,以探索微囊化对所考虑菌株的健康有益效果的影响。未包封的细胞在暴露于模拟胃液和其他应激条件下完全被破坏,而包封的细胞对人工肠液和热及渗透处理表现出明显更高的抗性。此外,在这项研究中,比较了含有β-葡聚糖 Pleuran 的各种微囊化益生菌菌株配方与类似配方的效果。微囊化有效地保护了所选细菌,无论是单一菌株还是三种菌株的混合物,无论是含有还是不含有 Pleuran 的配方,都能免受模拟胃肠道和工业处理条件的影响,从而在不显著影响其功能的情况下输送活菌。对每种单一菌株和三种菌株混合物的免疫调节特性的比较研究表明,益生菌混合物具有协同作用,但两种配方之间没有明显差异,因为 Pleuran 的作用被益生菌菌株的更高潜力所掩盖。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验